We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
The conditions that new cemetery developments, or new extensions of a cemetery, can operate under without needing an environmental permit.
How to use a quasi-experimental study to evaluate your digital health product.
Advises on how planning can manage potential noise impacts in new development.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Information on depleted uranium (DU) including what it is, its uses, health effects and protection from exposure.
How to carry out a flood risk assessment so that you can complete your planning application.
There have been a small number of reports of serious and life-threatening anticholinergic side effects associated with hyoscine hydrobromide patches, particularly when used outside the licence. Healthcare professionals, patients, parents and carers should be aware of the signs and symptoms...
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
Emerging techniques on how to prevent or minimise the environmental impacts of post-combustion carbon dioxide capture.
Emerging techniques on how to prevent or minimise the environmental impacts of industrial hydrogen production from methane or refinery fuel gas with carbon capture for storage.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Organisational definitions of terms concerned with risk and risk-related matters.
Dstl ensures the UK armed forces have the required weapons capability through research, development and demonstration of advances in science and technology.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.